MannKind Corporation (MNKD) Financial Statements (2024 and earlier)

Company Profile

Business Address 1 CASPER STREET
DANBURY, CT 06810
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments295,099170,846204,11667,00549,88471,157
Cash and cash equivalents238,48069,767124,18467,00529,90671,157
Short-term investments56,619101,07979,932 19,978 
Restricted cash and investments   158316527
Receivables14,90116,8014,9944,2183,5134,017
Inventory, net of allowances, customer advances and progress billings28,54521,7727,1524,9734,1553,597
Inventory28,54521,7727,1524,9734,1553,597
Other undisclosed current assets34,84825,4773,4823,1222,8892,556
Total current assets:373,393234,896219,74479,47660,75781,854
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization     
Operating lease, right-of-use asset     
Property, plant and equipment84,22045,12636,61225,86726,77825,602
Long-term investments and receivables7,1551,96156,619   
Long-term investments7,1551,96156,619   
Intangible assets, net (including goodwill)3,0043,581    
Goodwill1,9312,428    
Intangible assets, net (excluding goodwill)1,0731,153    
Other noncurrent assets7,4269,7188,1863,2656,190249
Other undisclosed noncurrent assets      
Total noncurrent assets:101,80560,386101,41729,13232,96825,851
TOTAL ASSETS:475,198295,282321,161108,60893,725107,705
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities51,61646,60534,37525,28920,69320,401
Accounts payable9,58011,0526,9565,5824,7895,379
Accrued liabilities42,03635,55327,41919,70715,90415,022
Deferred revenue9,0851,73382733,27532,503
Debt9,8099,5656,977 5,02811,298
Contract with customer, liability36,885
Other undisclosed current liabilities33,6159,3936,17015,1417,3946,657
Total current liabilities:104,12567,29648,34973,70565,61875,241
Noncurrent Liabilities
Long-term debt and lease obligation321,170319,909318,5096,2027,51419,099
Long-term debt, excluding current maturities226,851225,397223,9445,0005,00019,099
Finance lease, liability94,31994,51293,525  
Liabilities, other than long-term debt73,71951,85642,91864,68978,36482,769
Deferred revenue69,79437,68419,5431,6628,344
Contract with customer, liability10,680
Due to related parties8,82918,42563,02770,02072,089
Other liabilities   4,950   
Operating lease, liability3,9255,3431,0401,2022,514
Other undisclosed noncurrent liabilities222,352106,759120,734144,431132,755105,678
Total noncurrent liabilities:617,241478,524482,161215,322218,633207,546
Total liabilities:721,366545,820530,510289,027284,251282,787
Equity
Equity, attributable to parent(246,168)(250,538)(209,349)(180,419)(190,526)(175,082)
Common stock2,7002,6382,5152,4212,1181,870
Additional paid in capital2,980,5392,964,2932,918,2052,866,3032,799,2782,763,067
Accumulated other comprehensive loss     (19)(19)
Accumulated deficit(3,229,407)(3,217,469)(3,130,069)(3,049,143)(2,991,903)(2,940,000)
Total equity:(246,168)(250,538)(209,349)(180,419)(190,526)(175,082)
TOTAL LIABILITIES AND EQUITY:475,198295,282321,161108,60893,725107,705

Income Statement (P&L) ($ in thousands)

6/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues198,96299,77075,44265,14463,03827,859
Cost of revenue(127,513)(106,383)(28,414)(30,498)(25,094)(19,402)
Cost of goods and services sold(20,863)(16,003)(16,833)(15,084)(20,078)(19,402)
Gross profit:71,449(6,613)47,02834,64637,9448,457
Operating expenses(62,771)(57,497)(94,050)(82,559)(82,541)(88,453)
Other undisclosed operating income      3,401
Operating income (loss):8,678(64,110)(47,022)(47,913)(44,597)(76,595)
Nonoperating expense(19,055)(23,290)(33,904)(9,545)(7,306)(10,140)
Investment income, nonoperating6,1542,513112167997501
Interest and debt expense(15,151)(9,552)(17,200)(264)3,529(46)
Loss from continuing operations before equity method investments, income taxes:(25,528)(96,952)(98,126)(57,722)(48,374)(86,781)
Other undisclosed income (loss) from continuing operations before income taxes15,1519,55217,200264(3,529)46
Income (loss) from continuing operations before income taxes:(10,377)(87,400)(80,926)(57,458)(51,903)(86,735)
Income tax expense (benefit)(1,561)9,94019,6312185,252(240)
Other undisclosed loss from continuing operations      
Income (loss) from continuing operations:(11,938)(77,460)(61,295)(57,240)(46,651)(86,975)
Loss before gain (loss) on sale of properties:(61,295)(57,240)(46,651)(86,975)
Other undisclosed net loss  (9,940)(19,631) (5,252) 
Net income (loss) available to common stockholders, diluted:(11,938)(87,400)(80,926)(57,240)(51,903)(86,975)

Comprehensive Income ($ in thousands)

6/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net income (loss):(11,938)(87,400)(80,926)(57,240)(51,903)(86,975)
Comprehensive income (loss):(11,938)(87,400)(80,926)(57,240)(51,903)(86,975)
Other undisclosed comprehensive loss, net of tax, attributable to parent   (19) (1)
Comprehensive income (loss), net of tax, attributable to parent:(11,938)(87,400)(80,926)(57,259)(51,903)(86,976)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: